C-reactive protein in patients with advanced metastatic renal cell carcinoma: Usefulness in identifying patients most likely to benefit from initial nephrectomy

OBJECTIVE: C-reactive protein (CRP) is considered a useful serum marker for patients with RCC. However, its clinical utility in advanced metastatic renal cell carcinoma (AM-RCC), particularly in deciding whether to perform nephrectomy at the onset, is not well studied. PATIENTS AND METHODS: We retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Hiroki, Shioi, Koichi, Murakami, Takayuki, Takizawa, Akitoshi, Sano, Futoshi, Kawahara, Takashi, Mizuno, Nobuhiko, Makiyama, Kazuhide, Nakaigawa, Noboru, Kishida, Takeshi, Miura, Takeshi, Kubota, Yoshinobu, Yao, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487844/
https://www.ncbi.nlm.nih.gov/pubmed/22857740
http://dx.doi.org/10.1186/1471-2407-12-337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487844/
https://www.ncbi.nlm.nih.gov/pubmed/22857740
http://dx.doi.org/10.1186/1471-2407-12-337

Ejemplares similares